nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Cimetidine—obesity	0.231	1	CbGbCtD
Baclofen—GABBR2—hindbrain—obesity	0.0257	0.326	CbGeAlD
Baclofen—GABBR2—adrenal cortex—obesity	0.0132	0.167	CbGeAlD
Baclofen—GABBR2—adrenal gland—obesity	0.00949	0.121	CbGeAlD
Baclofen—GABBR2—endocrine gland—obesity	0.00823	0.105	CbGeAlD
Baclofen—GABBR1—adrenal cortex—obesity	0.00664	0.0844	CbGeAlD
Baclofen—GABBR1—pituitary gland—obesity	0.00536	0.0682	CbGeAlD
Baclofen—GABBR1—adipose tissue—obesity	0.00534	0.0679	CbGeAlD
Baclofen—GABBR1—adrenal gland—obesity	0.00479	0.0609	CbGeAlD
Baclofen—Ibuprofen—FABP2—obesity	0.00411	0.426	CrCbGaD
Baclofen—Chlorphenesin—CYP19A1—obesity	0.00131	0.136	CrCbGaD
Baclofen—Chlorphenesin—BCHE—obesity	0.00131	0.136	CrCbGaD
Baclofen—Ibuprofen—BCL2—obesity	0.00115	0.12	CrCbGaD
Baclofen—Ibuprofen—PPARG—obesity	0.000639	0.0663	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—obesity	0.000604	0.0627	CrCbGaD
Baclofen—Cardiac disorder—Bupropion—obesity	0.000338	0.000779	CcSEcCtD
Baclofen—Flushing—Bupropion—obesity	0.000338	0.000779	CcSEcCtD
Baclofen—Vertigo—Orlistat—obesity	0.000338	0.000779	CcSEcCtD
Baclofen—Ill-defined disorder—Sibutramine—obesity	0.000338	0.000778	CcSEcCtD
Baclofen—Anaemia—Sibutramine—obesity	0.000336	0.000775	CcSEcCtD
Baclofen—Diplopia—Topiramate—obesity	0.000336	0.000773	CcSEcCtD
Baclofen—Osteoarthritis—Topiramate—obesity	0.000336	0.000773	CcSEcCtD
Baclofen—Agitation—Sibutramine—obesity	0.000334	0.000771	CcSEcCtD
Baclofen—Palpitations—Orlistat—obesity	0.000332	0.000766	CcSEcCtD
Baclofen—Angiopathy—Bupropion—obesity	0.000331	0.000762	CcSEcCtD
Baclofen—Affect lability—Topiramate—obesity	0.00033	0.000761	CcSEcCtD
Baclofen—Nausea—Cimetidine—obesity	0.00033	0.000761	CcSEcCtD
Baclofen—Mediastinal disorder—Bupropion—obesity	0.000328	0.000757	CcSEcCtD
Baclofen—Malaise—Sibutramine—obesity	0.000328	0.000756	CcSEcCtD
Baclofen—Psychotic disorder—Topiramate—obesity	0.000328	0.000755	CcSEcCtD
Baclofen—Chills—Bupropion—obesity	0.000327	0.000754	CcSEcCtD
Baclofen—Vertigo—Sibutramine—obesity	0.000327	0.000753	CcSEcCtD
Baclofen—Syncope—Sibutramine—obesity	0.000326	0.000752	CcSEcCtD
Baclofen—Convulsion—Orlistat—obesity	0.000326	0.000751	CcSEcCtD
Baclofen—Arrhythmia—Bupropion—obesity	0.000326	0.00075	CcSEcCtD
Baclofen—Face oedema—Topiramate—obesity	0.000324	0.000747	CcSEcCtD
Baclofen—Alopecia—Bupropion—obesity	0.000322	0.000742	CcSEcCtD
Baclofen—Palpitations—Sibutramine—obesity	0.000322	0.000741	CcSEcCtD
Baclofen—Chest pain—Orlistat—obesity	0.00032	0.000738	CcSEcCtD
Baclofen—Myalgia—Orlistat—obesity	0.00032	0.000738	CcSEcCtD
Baclofen—Loss of consciousness—Sibutramine—obesity	0.00032	0.000737	CcSEcCtD
Baclofen—Mental disorder—Bupropion—obesity	0.000319	0.000736	CcSEcCtD
Baclofen—Urinary retention—Topiramate—obesity	0.000319	0.000735	CcSEcCtD
Baclofen—Anxiety—Orlistat—obesity	0.000319	0.000735	CcSEcCtD
Baclofen—Mood swings—Topiramate—obesity	0.000318	0.000733	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000318	0.000733	CcSEcCtD
Baclofen—Malnutrition—Bupropion—obesity	0.000317	0.000731	CcSEcCtD
Baclofen—Discomfort—Orlistat—obesity	0.000316	0.000729	CcSEcCtD
Baclofen—Ataxia—Topiramate—obesity	0.000316	0.000727	CcSEcCtD
Baclofen—Convulsion—Sibutramine—obesity	0.000315	0.000727	CcSEcCtD
Baclofen—Hypertension—Sibutramine—obesity	0.000314	0.000724	CcSEcCtD
Baclofen—Dry mouth—Orlistat—obesity	0.000313	0.000722	CcSEcCtD
Baclofen—Flatulence—Bupropion—obesity	0.000313	0.00072	CcSEcCtD
Baclofen—Dehydration—Topiramate—obesity	0.000312	0.000719	CcSEcCtD
Baclofen—Dysgeusia—Bupropion—obesity	0.000311	0.000716	CcSEcCtD
Baclofen—Chest pain—Sibutramine—obesity	0.00031	0.000714	CcSEcCtD
Baclofen—Myalgia—Sibutramine—obesity	0.00031	0.000714	CcSEcCtD
Baclofen—Anxiety—Sibutramine—obesity	0.000309	0.000712	CcSEcCtD
Baclofen—Oedema—Orlistat—obesity	0.000307	0.000707	CcSEcCtD
Baclofen—Back pain—Bupropion—obesity	0.000307	0.000707	CcSEcCtD
Baclofen—Orthostatic hypotension—Topiramate—obesity	0.000307	0.000706	CcSEcCtD
Baclofen—Discomfort—Sibutramine—obesity	0.000306	0.000705	CcSEcCtD
Baclofen—Infection—Orlistat—obesity	0.000305	0.000703	CcSEcCtD
Baclofen—Breast disorder—Topiramate—obesity	0.000303	0.000699	CcSEcCtD
Baclofen—Dry mouth—Sibutramine—obesity	0.000303	0.000698	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Topiramate—obesity	0.000302	0.000696	CcSEcCtD
Baclofen—Nervous system disorder—Orlistat—obesity	0.000301	0.000694	CcSEcCtD
Baclofen—Confusional state—Sibutramine—obesity	0.000299	0.00069	CcSEcCtD
Baclofen—Vision blurred—Bupropion—obesity	0.000299	0.000689	CcSEcCtD
Baclofen—Skin disorder—Orlistat—obesity	0.000298	0.000687	CcSEcCtD
Baclofen—Tremor—Bupropion—obesity	0.000297	0.000685	CcSEcCtD
Baclofen—Oedema—Sibutramine—obesity	0.000297	0.000684	CcSEcCtD
Baclofen—Hyperhidrosis—Orlistat—obesity	0.000297	0.000684	CcSEcCtD
Baclofen—Muscular weakness—Topiramate—obesity	0.000296	0.000682	CcSEcCtD
Baclofen—Infection—Sibutramine—obesity	0.000295	0.00068	CcSEcCtD
Baclofen—Ill-defined disorder—Bupropion—obesity	0.000294	0.000678	CcSEcCtD
Baclofen—Anaemia—Bupropion—obesity	0.000293	0.000676	CcSEcCtD
Baclofen—Shock—Sibutramine—obesity	0.000292	0.000673	CcSEcCtD
Baclofen—Agitation—Bupropion—obesity	0.000292	0.000672	CcSEcCtD
Baclofen—Dysphagia—Topiramate—obesity	0.00029	0.000668	CcSEcCtD
Baclofen—Tachycardia—Sibutramine—obesity	0.00029	0.000668	CcSEcCtD
Baclofen—Skin disorder—Sibutramine—obesity	0.000288	0.000665	CcSEcCtD
Baclofen—Hyperhidrosis—Sibutramine—obesity	0.000287	0.000662	CcSEcCtD
Baclofen—Malaise—Bupropion—obesity	0.000286	0.000659	CcSEcCtD
Baclofen—Vertigo—Bupropion—obesity	0.000285	0.000657	CcSEcCtD
Baclofen—Syncope—Bupropion—obesity	0.000284	0.000656	CcSEcCtD
Baclofen—Anorexia—Sibutramine—obesity	0.000283	0.000652	CcSEcCtD
Baclofen—Sweating increased—Topiramate—obesity	0.000283	0.000651	CcSEcCtD
Baclofen—Palpitations—Bupropion—obesity	0.00028	0.000646	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Orlistat—obesity	0.00028	0.000644	CcSEcCtD
Baclofen—Loss of consciousness—Bupropion—obesity	0.000279	0.000643	CcSEcCtD
Baclofen—Insomnia—Orlistat—obesity	0.000278	0.00064	CcSEcCtD
Baclofen—Hypotension—Sibutramine—obesity	0.000278	0.00064	CcSEcCtD
Baclofen—Paraesthesia—Orlistat—obesity	0.000276	0.000635	CcSEcCtD
Baclofen—Convulsion—Bupropion—obesity	0.000275	0.000633	CcSEcCtD
Baclofen—Hypertension—Bupropion—obesity	0.000274	0.000631	CcSEcCtD
Baclofen—Dysuria—Topiramate—obesity	0.000271	0.000625	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Sibutramine—obesity	0.000271	0.000624	CcSEcCtD
Baclofen—Dyspepsia—Orlistat—obesity	0.00027	0.000623	CcSEcCtD
Baclofen—Myalgia—Bupropion—obesity	0.00027	0.000622	CcSEcCtD
Baclofen—Chest pain—Bupropion—obesity	0.00027	0.000622	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—obesity	0.00027	0.028	CrCbGaD
Baclofen—Anxiety—Bupropion—obesity	0.000269	0.00062	CcSEcCtD
Baclofen—Insomnia—Sibutramine—obesity	0.000269	0.000619	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000268	0.000618	CcSEcCtD
Baclofen—Pollakiuria—Topiramate—obesity	0.000268	0.000618	CcSEcCtD
Baclofen—Erectile dysfunction—Topiramate—obesity	0.000267	0.000616	CcSEcCtD
Baclofen—Discomfort—Bupropion—obesity	0.000267	0.000615	CcSEcCtD
Baclofen—Decreased appetite—Orlistat—obesity	0.000267	0.000615	CcSEcCtD
Baclofen—Paraesthesia—Sibutramine—obesity	0.000267	0.000615	CcSEcCtD
Baclofen—Gastrointestinal disorder—Orlistat—obesity	0.000265	0.000611	CcSEcCtD
Baclofen—Dyspnoea—Sibutramine—obesity	0.000265	0.00061	CcSEcCtD
Baclofen—Fatigue—Orlistat—obesity	0.000265	0.00061	CcSEcCtD
Baclofen—Dry mouth—Bupropion—obesity	0.000264	0.000609	CcSEcCtD
Baclofen—Somnolence—Sibutramine—obesity	0.000264	0.000608	CcSEcCtD
Baclofen—Weight increased—Topiramate—obesity	0.000264	0.000608	CcSEcCtD
Baclofen—Weight decreased—Topiramate—obesity	0.000262	0.000605	CcSEcCtD
Baclofen—Pain—Orlistat—obesity	0.000262	0.000605	CcSEcCtD
Baclofen—Hyperglycaemia—Topiramate—obesity	0.000262	0.000603	CcSEcCtD
Baclofen—Dyspepsia—Sibutramine—obesity	0.000261	0.000602	CcSEcCtD
Baclofen—Confusional state—Bupropion—obesity	0.000261	0.000602	CcSEcCtD
Baclofen—Pneumonia—Topiramate—obesity	0.00026	0.0006	CcSEcCtD
Baclofen—Oedema—Bupropion—obesity	0.000259	0.000597	CcSEcCtD
Baclofen—Decreased appetite—Sibutramine—obesity	0.000258	0.000595	CcSEcCtD
Baclofen—Depression—Topiramate—obesity	0.000258	0.000594	CcSEcCtD
Baclofen—Infection—Bupropion—obesity	0.000257	0.000593	CcSEcCtD
Baclofen—Gastrointestinal disorder—Sibutramine—obesity	0.000256	0.000591	CcSEcCtD
Baclofen—Shock—Bupropion—obesity	0.000255	0.000587	CcSEcCtD
Baclofen—Renal failure—Topiramate—obesity	0.000254	0.000586	CcSEcCtD
Baclofen—Pain—Sibutramine—obesity	0.000254	0.000585	CcSEcCtD
Baclofen—Constipation—Sibutramine—obesity	0.000254	0.000585	CcSEcCtD
Baclofen—Nervous system disorder—Bupropion—obesity	0.000254	0.000585	CcSEcCtD
Baclofen—Feeling abnormal—Orlistat—obesity	0.000253	0.000583	CcSEcCtD
Baclofen—Tachycardia—Bupropion—obesity	0.000253	0.000582	CcSEcCtD
Baclofen—Skin disorder—Bupropion—obesity	0.000251	0.00058	CcSEcCtD
Baclofen—Gastrointestinal pain—Orlistat—obesity	0.000251	0.000578	CcSEcCtD
Baclofen—Hyperhidrosis—Bupropion—obesity	0.00025	0.000577	CcSEcCtD
Baclofen—Anorexia—Bupropion—obesity	0.000247	0.000569	CcSEcCtD
Baclofen—Haematuria—Topiramate—obesity	0.000247	0.000568	CcSEcCtD
Baclofen—Feeling abnormal—Sibutramine—obesity	0.000245	0.000564	CcSEcCtD
Baclofen—Urticaria—Orlistat—obesity	0.000244	0.000562	CcSEcCtD
Baclofen—Gastrointestinal pain—Sibutramine—obesity	0.000243	0.00056	CcSEcCtD
Baclofen—Abdominal pain—Orlistat—obesity	0.000243	0.000559	CcSEcCtD
Baclofen—Body temperature increased—Orlistat—obesity	0.000243	0.000559	CcSEcCtD
Baclofen—Hypotension—Bupropion—obesity	0.000242	0.000558	CcSEcCtD
Baclofen—Ibuprofen—ALB—obesity	0.00024	0.0249	CrCbGaD
Baclofen—Bradycardia—Topiramate—obesity	0.000236	0.000545	CcSEcCtD
Baclofen—Urticaria—Sibutramine—obesity	0.000236	0.000544	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Bupropion—obesity	0.000236	0.000544	CcSEcCtD
Baclofen—Body temperature increased—Sibutramine—obesity	0.000235	0.000541	CcSEcCtD
Baclofen—Abdominal pain—Sibutramine—obesity	0.000235	0.000541	CcSEcCtD
Baclofen—Insomnia—Bupropion—obesity	0.000234	0.00054	CcSEcCtD
Baclofen—Rhinitis—Topiramate—obesity	0.000233	0.000536	CcSEcCtD
Baclofen—Paraesthesia—Bupropion—obesity	0.000232	0.000536	CcSEcCtD
Baclofen—Hypoaesthesia—Topiramate—obesity	0.000231	0.000532	CcSEcCtD
Baclofen—Hallucination—Topiramate—obesity	0.000231	0.000532	CcSEcCtD
Baclofen—Dyspnoea—Bupropion—obesity	0.000231	0.000532	CcSEcCtD
Baclofen—Somnolence—Bupropion—obesity	0.00023	0.00053	CcSEcCtD
Baclofen—Urinary tract disorder—Topiramate—obesity	0.000229	0.000528	CcSEcCtD
Baclofen—Oedema peripheral—Topiramate—obesity	0.000229	0.000527	CcSEcCtD
Baclofen—Connective tissue disorder—Topiramate—obesity	0.000228	0.000526	CcSEcCtD
Baclofen—Dyspepsia—Bupropion—obesity	0.000228	0.000525	CcSEcCtD
Baclofen—Urethral disorder—Topiramate—obesity	0.000228	0.000525	CcSEcCtD
Baclofen—Decreased appetite—Bupropion—obesity	0.000225	0.000519	CcSEcCtD
Baclofen—Visual impairment—Topiramate—obesity	0.000224	0.000516	CcSEcCtD
Baclofen—Gastrointestinal disorder—Bupropion—obesity	0.000224	0.000515	CcSEcCtD
Baclofen—Fatigue—Bupropion—obesity	0.000223	0.000514	CcSEcCtD
Baclofen—Pain—Bupropion—obesity	0.000221	0.00051	CcSEcCtD
Baclofen—Constipation—Bupropion—obesity	0.000221	0.00051	CcSEcCtD
Baclofen—Asthenia—Orlistat—obesity	0.00022	0.000507	CcSEcCtD
Baclofen—Pruritus—Orlistat—obesity	0.000217	0.0005	CcSEcCtD
Baclofen—Eye disorder—Topiramate—obesity	0.000217	0.0005	CcSEcCtD
Baclofen—Tinnitus—Topiramate—obesity	0.000216	0.000499	CcSEcCtD
Baclofen—Flushing—Topiramate—obesity	0.000215	0.000497	CcSEcCtD
Baclofen—Cardiac disorder—Topiramate—obesity	0.000215	0.000497	CcSEcCtD
Baclofen—Feeling abnormal—Bupropion—obesity	0.000213	0.000492	CcSEcCtD
Baclofen—Asthenia—Sibutramine—obesity	0.000213	0.000491	CcSEcCtD
Baclofen—Gastrointestinal pain—Bupropion—obesity	0.000212	0.000488	CcSEcCtD
Baclofen—Angiopathy—Topiramate—obesity	0.000211	0.000485	CcSEcCtD
Baclofen—Pruritus—Sibutramine—obesity	0.00021	0.000484	CcSEcCtD
Baclofen—Diarrhoea—Orlistat—obesity	0.00021	0.000484	CcSEcCtD
Baclofen—Mediastinal disorder—Topiramate—obesity	0.000209	0.000482	CcSEcCtD
Baclofen—Chills—Topiramate—obesity	0.000208	0.00048	CcSEcCtD
Baclofen—Urticaria—Bupropion—obesity	0.000206	0.000474	CcSEcCtD
Baclofen—Alopecia—Topiramate—obesity	0.000205	0.000473	CcSEcCtD
Baclofen—Abdominal pain—Bupropion—obesity	0.000205	0.000472	CcSEcCtD
Baclofen—Body temperature increased—Bupropion—obesity	0.000205	0.000472	CcSEcCtD
Baclofen—Mental disorder—Topiramate—obesity	0.000203	0.000469	CcSEcCtD
Baclofen—Diarrhoea—Sibutramine—obesity	0.000203	0.000468	CcSEcCtD
Baclofen—Dizziness—Orlistat—obesity	0.000203	0.000468	CcSEcCtD
Baclofen—Malnutrition—Topiramate—obesity	0.000202	0.000466	CcSEcCtD
Baclofen—Flatulence—Topiramate—obesity	0.000199	0.000459	CcSEcCtD
Baclofen—Dysgeusia—Topiramate—obesity	0.000198	0.000456	CcSEcCtD
Baclofen—Dizziness—Sibutramine—obesity	0.000196	0.000453	CcSEcCtD
Baclofen—Back pain—Topiramate—obesity	0.000196	0.000451	CcSEcCtD
Baclofen—Vomiting—Orlistat—obesity	0.000195	0.00045	CcSEcCtD
Baclofen—Rash—Orlistat—obesity	0.000193	0.000446	CcSEcCtD
Baclofen—Dermatitis—Orlistat—obesity	0.000193	0.000446	CcSEcCtD
Baclofen—Headache—Orlistat—obesity	0.000192	0.000443	CcSEcCtD
Baclofen—Vision blurred—Topiramate—obesity	0.00019	0.000439	CcSEcCtD
Baclofen—Tremor—Topiramate—obesity	0.000189	0.000436	CcSEcCtD
Baclofen—Vomiting—Sibutramine—obesity	0.000189	0.000435	CcSEcCtD
Baclofen—Ill-defined disorder—Topiramate—obesity	0.000188	0.000432	CcSEcCtD
Baclofen—Rash—Sibutramine—obesity	0.000187	0.000432	CcSEcCtD
Baclofen—Dermatitis—Sibutramine—obesity	0.000187	0.000431	CcSEcCtD
Baclofen—Anaemia—Topiramate—obesity	0.000187	0.000431	CcSEcCtD
Baclofen—Headache—Sibutramine—obesity	0.000186	0.000429	CcSEcCtD
Baclofen—Asthenia—Bupropion—obesity	0.000186	0.000428	CcSEcCtD
Baclofen—Agitation—Topiramate—obesity	0.000186	0.000428	CcSEcCtD
Baclofen—Pruritus—Bupropion—obesity	0.000183	0.000422	CcSEcCtD
Baclofen—Nausea—Orlistat—obesity	0.000182	0.00042	CcSEcCtD
Baclofen—Malaise—Topiramate—obesity	0.000182	0.00042	CcSEcCtD
Baclofen—Vertigo—Topiramate—obesity	0.000182	0.000418	CcSEcCtD
Baclofen—Syncope—Topiramate—obesity	0.000181	0.000418	CcSEcCtD
Baclofen—Palpitations—Topiramate—obesity	0.000179	0.000412	CcSEcCtD
Baclofen—Loss of consciousness—Topiramate—obesity	0.000178	0.000409	CcSEcCtD
Baclofen—Diarrhoea—Bupropion—obesity	0.000177	0.000408	CcSEcCtD
Baclofen—Nausea—Sibutramine—obesity	0.000176	0.000407	CcSEcCtD
Baclofen—Convulsion—Topiramate—obesity	0.000175	0.000404	CcSEcCtD
Baclofen—Hypertension—Topiramate—obesity	0.000174	0.000402	CcSEcCtD
Baclofen—Myalgia—Topiramate—obesity	0.000172	0.000397	CcSEcCtD
Baclofen—Chest pain—Topiramate—obesity	0.000172	0.000397	CcSEcCtD
Baclofen—Anxiety—Topiramate—obesity	0.000171	0.000395	CcSEcCtD
Baclofen—Dizziness—Bupropion—obesity	0.000171	0.000395	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000171	0.000394	CcSEcCtD
Baclofen—Discomfort—Topiramate—obesity	0.00017	0.000392	CcSEcCtD
Baclofen—Dry mouth—Topiramate—obesity	0.000168	0.000388	CcSEcCtD
Baclofen—Confusional state—Topiramate—obesity	0.000166	0.000383	CcSEcCtD
Baclofen—Oedema—Topiramate—obesity	0.000165	0.00038	CcSEcCtD
Baclofen—Vomiting—Bupropion—obesity	0.000165	0.000379	CcSEcCtD
Baclofen—Infection—Topiramate—obesity	0.000164	0.000378	CcSEcCtD
Baclofen—Rash—Bupropion—obesity	0.000163	0.000376	CcSEcCtD
Baclofen—Dermatitis—Bupropion—obesity	0.000163	0.000376	CcSEcCtD
Baclofen—Shock—Topiramate—obesity	0.000162	0.000374	CcSEcCtD
Baclofen—Headache—Bupropion—obesity	0.000162	0.000374	CcSEcCtD
Baclofen—Nervous system disorder—Topiramate—obesity	0.000162	0.000373	CcSEcCtD
Baclofen—Tachycardia—Topiramate—obesity	0.000161	0.000371	CcSEcCtD
Baclofen—Skin disorder—Topiramate—obesity	0.00016	0.000369	CcSEcCtD
Baclofen—Hyperhidrosis—Topiramate—obesity	0.000159	0.000368	CcSEcCtD
Baclofen—Anorexia—Topiramate—obesity	0.000157	0.000362	CcSEcCtD
Baclofen—Hypotension—Topiramate—obesity	0.000154	0.000355	CcSEcCtD
Baclofen—Nausea—Bupropion—obesity	0.000154	0.000354	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Topiramate—obesity	0.00015	0.000346	CcSEcCtD
Baclofen—Insomnia—Topiramate—obesity	0.000149	0.000344	CcSEcCtD
Baclofen—Paraesthesia—Topiramate—obesity	0.000148	0.000341	CcSEcCtD
Baclofen—Dyspnoea—Topiramate—obesity	0.000147	0.000339	CcSEcCtD
Baclofen—Somnolence—Topiramate—obesity	0.000147	0.000338	CcSEcCtD
Baclofen—Dyspepsia—Topiramate—obesity	0.000145	0.000335	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CNR1—obesity	0.000145	0.000586	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CRH—obesity	0.000144	0.000585	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR1B—obesity	0.000144	0.000585	CbGpPWpGaD
Baclofen—Decreased appetite—Topiramate—obesity	0.000143	0.00033	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SDC1—obesity	0.000143	0.000578	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Topiramate—obesity	0.000142	0.000328	CcSEcCtD
Baclofen—Fatigue—Topiramate—obesity	0.000142	0.000328	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PRKCD—obesity	0.000142	0.000577	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRB1—obesity	0.000142	0.000574	CbGpPWpGaD
Baclofen—Constipation—Topiramate—obesity	0.000141	0.000325	CcSEcCtD
Baclofen—Pain—Topiramate—obesity	0.000141	0.000325	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—DRD2—obesity	0.000141	0.000572	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKR1C3—obesity	0.00014	0.000569	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEPR—obesity	0.00014	0.000569	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GCG—obesity	0.00014	0.000566	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—POMC—obesity	0.00014	0.000566	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HTR2A—obesity	0.000139	0.000564	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—C3—obesity	0.000139	0.000564	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GHRL—obesity	0.000139	0.000562	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DRD4—obesity	0.000137	0.000557	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NPS—obesity	0.000137	0.000554	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL2—obesity	0.000137	0.000554	CbGpPWpGaD
Baclofen—Feeling abnormal—Topiramate—obesity	0.000136	0.000313	CcSEcCtD
Baclofen—Gastrointestinal pain—Topiramate—obesity	0.000135	0.000311	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PRKCB—obesity	0.000134	0.000545	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—F2—obesity	0.000134	0.000545	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD1—obesity	0.000134	0.000544	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR2C—obesity	0.000134	0.000544	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGT—obesity	0.000132	0.000536	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CNR1—obesity	0.000131	0.000532	CbGpPWpGaD
Baclofen—Urticaria—Topiramate—obesity	0.000131	0.000302	CcSEcCtD
Baclofen—Abdominal pain—Topiramate—obesity	0.00013	0.000301	CcSEcCtD
Baclofen—Body temperature increased—Topiramate—obesity	0.00013	0.000301	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NTRK2—obesity	0.00013	0.000529	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC22A1—obesity	0.00013	0.000527	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRB1—obesity	0.00013	0.000526	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CG—obesity	0.000129	0.000521	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—DRD2—obesity	0.000128	0.000519	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GHRL—obesity	0.000127	0.000515	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PARP1—obesity	0.000127	0.000515	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GCG—obesity	0.000127	0.000514	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB2—obesity	0.000126	0.000512	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD4—obesity	0.000126	0.000511	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB3—obesity	0.000125	0.000509	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GAL—obesity	0.000123	0.000497	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—POMC—obesity	0.000122	0.000496	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PRKCB—obesity	0.000122	0.000495	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—F2—obesity	0.000122	0.000495	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—C5AR1—obesity	0.000121	0.000492	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CNR1—obesity	0.00012	0.000488	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GNB3—obesity	0.00012	0.000488	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PRKAR2B—obesity	0.00012	0.000486	CbGpPWpGaD
Baclofen—Asthenia—Topiramate—obesity	0.000118	0.000273	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—TCF7L2—obesity	0.000118	0.000479	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT2—obesity	0.000118	0.000477	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—DRD2—obesity	0.000117	0.000476	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GNAS—obesity	0.000117	0.000475	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—obesity	0.000117	0.000474	CbGpPWpGaD
Baclofen—Pruritus—Topiramate—obesity	0.000117	0.000269	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—GCG—obesity	0.000116	0.000471	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTPN1—obesity	0.000116	0.000471	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ADRB2—obesity	0.000115	0.000465	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—obesity	0.000113	0.000458	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GCK—obesity	0.000113	0.000458	CbGpPWpGaD
Baclofen—Diarrhoea—Topiramate—obesity	0.000113	0.00026	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCL5—obesity	0.000112	0.000454	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—POMC—obesity	0.000111	0.000451	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCK—obesity	0.000111	0.00045	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKG1—obesity	0.000111	0.00045	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRL—obesity	0.000111	0.00045	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STK11—obesity	0.000109	0.000443	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNB3—obesity	0.000109	0.000443	CbGpPWpGaD
Baclofen—Dizziness—Topiramate—obesity	0.000109	0.000251	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CETP—obesity	0.000109	0.000442	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL2—obesity	0.000109	0.000441	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLP1R—obesity	0.000108	0.000438	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLG—obesity	0.000108	0.000438	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RBP4—obesity	0.000108	0.000438	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—RHOA—obesity	0.000108	0.000437	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TF—obesity	0.000108	0.000437	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT2—obesity	0.000107	0.000433	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3R1—obesity	0.000107	0.000433	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GNAS—obesity	0.000106	0.000431	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRH3—obesity	0.000106	0.000431	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCKAR—obesity	0.000106	0.000431	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FOXO3—obesity	0.000105	0.000428	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADRB2—obesity	0.000105	0.000426	CbGpPWpGaD
Baclofen—Vomiting—Topiramate—obesity	0.000105	0.000242	CcSEcCtD
Baclofen—Rash—Topiramate—obesity	0.000104	0.00024	CcSEcCtD
Baclofen—Dermatitis—Topiramate—obesity	0.000104	0.000239	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SOCS1—obesity	0.000104	0.00042	CbGpPWpGaD
Baclofen—Headache—Topiramate—obesity	0.000103	0.000238	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TFRC—obesity	0.000103	0.000419	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—obesity	0.000103	0.000416	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SOCS3—obesity	0.000102	0.000415	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKAR2B—obesity	0.000102	0.000415	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL5—obesity	0.000102	0.000413	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCD—obesity	0.000101	0.000409	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GNB3—obesity	0.0001	0.000406	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NCF2—obesity	9.88e-05	0.000401	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR2A—obesity	9.87e-05	0.000401	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—TYK2—obesity	9.87e-05	0.0004	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—C3—obesity	9.86e-05	0.0004	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—obesity	9.85e-05	0.0004	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF2—obesity	9.84e-05	0.000399	CbGpPWpGaD
Baclofen—Nausea—Topiramate—obesity	9.8e-05	0.000226	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RHOA—obesity	9.79e-05	0.000397	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GNAS—obesity	9.75e-05	0.000395	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3R1—obesity	9.69e-05	0.000393	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NPY—obesity	9.63e-05	0.00039	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IAPP—obesity	9.57e-05	0.000388	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOC3—obesity	9.57e-05	0.000388	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOB—obesity	9.55e-05	0.000387	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGT—obesity	9.37e-05	0.00038	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL5—obesity	9.32e-05	0.000378	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR1B—obesity	9.29e-05	0.000377	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CRH—obesity	9.29e-05	0.000377	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SDC1—obesity	9.18e-05	0.000373	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCD—obesity	9.16e-05	0.000372	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LPL—obesity	9.12e-05	0.00037	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FOXO1—obesity	9.05e-05	0.000367	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RPS6KB1—obesity	9.04e-05	0.000366	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKR1C3—obesity	9.04e-05	0.000366	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HTR2A—obesity	8.97e-05	0.000364	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—C3—obesity	8.95e-05	0.000363	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—obesity	8.95e-05	0.000363	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—obesity	8.9e-05	0.000361	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NPS—obesity	8.8e-05	0.000357	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC2A4—obesity	8.78e-05	0.000356	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CYCS—obesity	8.66e-05	0.000351	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—F2—obesity	8.66e-05	0.000351	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCB—obesity	8.66e-05	0.000351	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD1—obesity	8.63e-05	0.00035	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR2C—obesity	8.63e-05	0.00035	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AGT—obesity	8.51e-05	0.000345	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCD—obesity	8.4e-05	0.000341	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NTRK2—obesity	8.4e-05	0.000341	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NCOA1—obesity	8.37e-05	0.00034	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB1—obesity	8.36e-05	0.000339	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—obesity	8.28e-05	0.000336	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR2A—obesity	8.22e-05	0.000333	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—C3—obesity	8.21e-05	0.000333	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PARP1—obesity	8.19e-05	0.000332	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GHRL—obesity	8.19e-05	0.000332	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLG—obesity	8.16e-05	0.000331	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD4—obesity	8.12e-05	0.000329	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—POMC—obesity	7.89e-05	0.00032	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCB—obesity	7.86e-05	0.000319	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—F2—obesity	7.86e-05	0.000319	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS2—obesity	7.81e-05	0.000317	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGT—obesity	7.8e-05	0.000316	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR1—obesity	7.75e-05	0.000314	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LEP—obesity	7.64e-05	0.00031	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOE—obesity	7.64e-05	0.00031	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TCF7L2—obesity	7.62e-05	0.000309	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT2—obesity	7.58e-05	0.000307	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CAV1—obesity	7.57e-05	0.000307	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GNB3—obesity	7.57e-05	0.000307	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DRD2—obesity	7.56e-05	0.000307	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOA1—obesity	7.55e-05	0.000306	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—obesity	7.53e-05	0.000305	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—obesity	7.52e-05	0.000305	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTPN1—obesity	7.49e-05	0.000304	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GCG—obesity	7.49e-05	0.000304	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—GNAS—obesity	7.37e-05	0.000299	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ESR1—obesity	7.3e-05	0.000296	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—obesity	7.28e-05	0.000295	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOB—obesity	7.21e-05	0.000293	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—F2—obesity	7.21e-05	0.000292	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCB—obesity	7.21e-05	0.000292	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—POMC—obesity	7.16e-05	0.00029	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRL—obesity	7.14e-05	0.00029	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BAD—obesity	7.12e-05	0.000289	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STK11—obesity	7.04e-05	0.000286	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL2—obesity	7.01e-05	0.000284	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLG—obesity	6.96e-05	0.000282	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—RHOA—obesity	6.95e-05	0.000282	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—obesity	6.9e-05	0.00028	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT2—obesity	6.88e-05	0.000279	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3R1—obesity	6.88e-05	0.000279	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS1—obesity	6.82e-05	0.000277	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FOXO3—obesity	6.79e-05	0.000276	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB2—obesity	6.78e-05	0.000275	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS1—obesity	6.67e-05	0.000271	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—obesity	6.61e-05	0.000268	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SOCS3—obesity	6.59e-05	0.000267	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—POMC—obesity	6.56e-05	0.000266	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—INS—obesity	6.53e-05	0.000265	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNB3—obesity	6.45e-05	0.000262	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL2—obesity	6.42e-05	0.000261	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—TYK2—obesity	6.36e-05	0.000258	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—obesity	6.35e-05	0.000257	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF2—obesity	6.34e-05	0.000257	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1—obesity	6.31e-05	0.000256	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RHOA—obesity	6.31e-05	0.000256	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT2—obesity	6.31e-05	0.000256	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GNAS—obesity	6.28e-05	0.000255	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3R1—obesity	6.25e-05	0.000253	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOB—obesity	6.15e-05	0.00025	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PPARA—obesity	6.08e-05	0.000247	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—obesity	6.06e-05	0.000246	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL5—obesity	6.01e-05	0.000244	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—obesity	6.01e-05	0.000244	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—obesity	6e-05	0.000243	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LPL—obesity	5.87e-05	0.000238	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TYK2—obesity	5.83e-05	0.000237	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FOXO1—obesity	5.83e-05	0.000237	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RPS6KB1—obesity	5.82e-05	0.000236	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RHOA—obesity	5.78e-05	0.000235	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—obesity	5.76e-05	0.000234	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOS3—obesity	5.72e-05	0.000232	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3R1—obesity	5.72e-05	0.000232	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOA1—obesity	5.71e-05	0.000231	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—obesity	5.45e-05	0.000221	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCD—obesity	5.41e-05	0.00022	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR2A—obesity	5.3e-05	0.000215	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—C3—obesity	5.29e-05	0.000215	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—obesity	5.28e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—obesity	5.28e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS2—obesity	5.03e-05	0.000204	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGT—obesity	5.03e-05	0.000204	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEP—obesity	4.92e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOE—obesity	4.92e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—obesity	4.91e-05	0.000199	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CAV1—obesity	4.88e-05	0.000198	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA1—obesity	4.87e-05	0.000197	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—obesity	4.83e-05	0.000196	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ESR1—obesity	4.7e-05	0.000191	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCB—obesity	4.64e-05	0.000188	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—F2—obesity	4.64e-05	0.000188	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—obesity	4.59e-05	0.000186	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BAD—obesity	4.59e-05	0.000186	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—obesity	4.52e-05	0.000183	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK8—obesity	4.47e-05	0.000181	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—obesity	4.45e-05	0.000181	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—obesity	4.44e-05	0.00018	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS1—obesity	4.39e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—POMC—obesity	4.23e-05	0.000172	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—INS—obesity	4.21e-05	0.000171	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL2—obesity	4.14e-05	0.000168	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—obesity	4.08e-05	0.000166	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1—obesity	4.07e-05	0.000165	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT2—obesity	4.07e-05	0.000165	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—obesity	3.91e-05	0.000158	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—obesity	3.87e-05	0.000157	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—obesity	3.86e-05	0.000157	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—obesity	3.79e-05	0.000154	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—obesity	3.79e-05	0.000154	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TYK2—obesity	3.76e-05	0.000152	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RHOA—obesity	3.73e-05	0.000151	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3R1—obesity	3.69e-05	0.00015	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOS3—obesity	3.69e-05	0.00015	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—obesity	3.51e-05	0.000143	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—obesity	3.41e-05	0.000138	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—obesity	3.41e-05	0.000138	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—obesity	3.22e-05	0.000131	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—obesity	3.16e-05	0.000128	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—obesity	3.11e-05	0.000126	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—obesity	2.96e-05	0.00012	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK8—obesity	2.88e-05	0.000117	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—obesity	2.87e-05	0.000116	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—obesity	2.85e-05	0.000116	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—obesity	2.63e-05	0.000107	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—obesity	2.63e-05	0.000107	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—obesity	2.45e-05	9.92e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—obesity	2.44e-05	9.89e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—obesity	2.08e-05	8.42e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—obesity	1.84e-05	7.46e-05	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—obesity	1.7e-05	6.88e-05	CbGpPWpGaD
